Chief Scientific Officer
Chief Medical Officer
Bone Therapeutics is a leading Belgian based biotechnology company specialising in the development of cell therapy products for orthopaedics and bone diseases. Its unique technology allows the Company to produce biologically active bone cells that are able to regenerate a healthy bone environment and promote bone regeneration.
Currently Headquartered in Gosselies, Belgium, the business has a strong executive team led by Miguel Forte, Chief Executive Officer. One of Miguel’s key objectives at Bone Therapeutics is to bring a unique value proposition by developing a range of innovative cell therapy products composed of differentiated bone-forming cells that can be administered via a minimally invasive procedure. These differentiated cells should offer significant advantages in respect of safety and efficacy compared to undifferentiated stem cells.
To assist Miguel in driving the business forward he engaged Tom Bradley and Stuart Penney to undertake two business critical searches for a Chief Scientific Officer and a Chief Medical Officer. Having successfully completed these assignments with outstanding candidates from the US and Spain respectively the incumbents will be an integral part of the executive leadership team and will be pivotal in strengthening the quality and progress of Bone Therapeutic’s pipeline focusing on providing crucial scientific, clinical and translational medicine input to early-stage R&D projects.
“Tom and Stuart’s network, energy and focus were instrumental for the success in the CSO and CMO appointments. Their understanding of Bone Therapeutic’s business priorities and vision together with their constant availability made the executive search process very effective and a real pleasure!”
Miguel Forte, Chief Executive Officer, Bone Therapeutics
